AMZN
Amazon.com, Inc.
AMZN has the edge over TM overall, supported by stronger modeled upside and stronger valuation.
TM
Toyota Motor Corporation
TM's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
TM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Weak |
TM's profitability is currently healthy, and its revenue is stable, but its cash flow and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over TM in the historical PE scenario, which offers more potential upside but is not a forecast.
TM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.9x | $175 | -16% |
| Current | 9.4x | $210 | — |
| Fair | 10x | $225 | +7.5% |
| Expensive | 13x | $290 | +38% |
Historical ranges are pointers, not guarantees.
TM's PE is 9.4x, but its earnings don't support one, so it isn't a reliable read right now.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over TM on the outlook, with more favorable revenue expectations.
TM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect TM's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over TM on earnings, with more consistent year-over-year improvement.
TM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $22.31 | +9.3% |
| Q1 2026 | $18.69 | -17% |
| Q4 2025 | $17.86 | -26% |
| Q3 2025 | $22.19 | +12% |
| Q2 2025 | $20.41 | -12% |
| Q1 2025 | $22.57 | -1.6% |
| Q4 2024 | $24.03 | +15% |
| Q3 2024 | $19.86 | +11% |
TM earned $22.31 per share over the past year, up 9.3% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over TM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over TM on profitability, with a higher operating margin.
TM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $85.9B | +12% |
| Q1 2026 | $80.4B | +3.8% |
| Q4 2025 | $85.9B | +11% |
| Q3 2025 | $77.6B | +8.2% |
| Q2 2025 | $76.8B | +3.5% |
| Q1 2025 | $77.5B | +12% |
| Q4 2024 | $77.7B | +2.9% |
| Q3 2024 | $71.7B | +0.1% |
TM's revenue has grown year over year for 18 quarters in a row: $85.9B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.9% | -1.7 points |
| Q1 2026 | 4.5% | -4.5 points |
| Q4 2025 | 8.8% | -1 points |
| Q3 2025 | 6.8% | -3.3 points |
| Q2 2025 | 9.5% | -1.5 points |
| Q1 2025 | 9% | -1 points |
| Q4 2024 | 9.8% | -4.2 points |
| Q3 2024 | 10% | -2.5 points |
TM's operating margin was 7.9% last quarter, down 1.7 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
TM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4.8B | -221% |
| Q1 2026 | $1.5B | +153% |
| Q4 2025 | -$3.1B | +$320.6M |
| Q3 2025 | -$1.3B | +$610.4M |
| Q2 2025 | $4B | +$4B |
| Q1 2025 | $592.5M | +$592.7M |
| Q4 2024 | -$3.4B | +$1.1B |
| Q3 2024 | -$1.9B | -$637.3M |
TM has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
TM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -6.1% | -79.5M shares |
| 1 year | -6.1% | -79.4M shares |
| 3 years | -9.7% | -132M shares |
| 5 years | -12% | -174M shares |
| Available history | -14% | -202M shares |
TM has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $22.9B |
| Q1 2026 | $50,144 |
| Q4 2025 | $50,144 |
| Q3 2025 | $37,608 |
| Q2 2025 | $250.4M |
| Q1 2025 | $835.4M |
| Q4 2024 | $891.9M |
| Q3 2024 | $5.5B |
TM spent $22.9B buying back its own shares over the past year, about three times what it spent the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over TM on leverage, with a lower net debt burden relative to earnings.
TM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.5x | High |
| Q1 2026 | 4.1x | High |
| Q4 2025 | 4.7x | High |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 3.7x | Elevated |
| Q1 2025 | 3.4x | Elevated |
| Q4 2024 | 3.3x | Elevated |
| Q3 2024 | 3.4x | Elevated |
TM's net debt is about 4.5 years of its operating earnings (EBITDA), up from 3.7 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
TM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.2 | Neutral |
| Stochastic | 77.3 | Neutral |
TM's weekly RSI is 60 (neutral) and its Stochastic is 77 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
TM PE vs Consumer Cyclical Sector
| Metric | TM | Sector median | Relative |
|---|---|---|---|
| PE | 9.4x | 18x | 48% below |
| PE % | 35 | 47 | 12 pts below |
TM has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
TM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $196.3 | 6.8% above |
| 20 week MA | $191.3 | 9.6% above |
| 50 week MA | $201.5 | 4% above |
| 100 week MA | $194.5 | 7.8% above |
| 200 week MA | $187.8 | 12% above |
TM is in an uptrend: it's above all five of its weekly moving averages, and 12% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over TM on returns for 2026, with the stronger performance.
TM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $141.3 | $150.5 | +6.5% |
| 2021 | $150.5 | $183.8 | +22% |
| 2022 | $183.8 | $137.1 | -25% |
| 2023 | $137.1 | $183.4 | +34% |
| 2024 | $183.4 | $199.5 | +8.8% |
| 2025 | $199.5 | $216.6 | +8.6% |
| 2026 YTD | $216.6 | $209.7 | -3.2% |
TM has finished higher in five of the last six years. It's down 3.2% so far in 2026.